title: Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation.
abstract: The management of prolonged urinary retention following pubovaginal sling surgery typically involves transvaginal urethrolysis for anatomical urethral obstruction. Brubaker recently reported on urethral sphincter abnormalities as a cause of postoperative urinary retention following either Burch suspension or a pubovaginal sling procedure. We report a case of functional urethral obstruction and detrusor acontractility following pubovaginal sling surgery that was successfully treated by botulinum A toxin urethral sphincter injection.
authors: University of Pittsburgh School of Medicine, Pennsylvania, USA.
authors: C P
authors: CP
authors: Smith
authors: M
authors: M
authors: O'Leary
authors: J
authors: J
authors: Erickson
authors: G T
authors: GT
authors: Somogyi
authors: M B
authors: MB
authors: Chancellor
mesh_terms: D000368:Aged; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007267:Injections; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D011183:Postoperative Complications; D011630:Pubic Bone / Q000601:surgery*; D014521:Urethra / Q000187:drug effects*; D016055:Urinary Retention / Q000188:drug therapy* / Q000209:etiology*; D013520:Urologic Surgical Procedures / Q000009:adverse effects*; D014621:Vagina / Q000601:surgery*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A